CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company
CERENOME, INC.
Sign in to watch- Ticker
- CNSY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330827593
- Phone
- 737.255.7194
- Business address
- 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
- Former names
- PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 37 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-01-11 | Swissquote Bank SA 10% owner | Sale | −12,630 | $0.34 | $4K | 5,348,229 |
| 2018-01-11 | Swissquote Bank SA 10% owner | Sale | −20,000 | $0.34 | $7K | 5,328,229 |
| 2018-01-10 | Swissquote Bank SA 10% owner | Sale | −15,796 | $0.38 | $6K | 5,400,859 |
| 2018-01-09 | Swissquote Bank SA 10% owner | Sale | −20,000 | $0.37 | $7K | 5,496,655 |
| 2018-01-09 | Swissquote Bank SA 10% owner | Sale | −20,000 | $0.38 | $8K | 5,476,655 |
| 2018-01-09 | Swissquote Bank SA 10% owner | Sale | −20,000 | $0.38 | $8K | 5,456,655 |
| 2018-01-09 | Swissquote Bank SA 10% owner | Sale | −20,000 | $0.40 | $8K | 5,436,655 |
| 2018-01-09 | Swissquote Bank SA 10% owner | Sale | −20,000 | $0.39 | $8K | 5,416,655 |
| 2017-11-28 | LYONS GARY A Director | Option exercise · Subscription Rights (Right to Buy) | −1 | 0 | ||
| 2017-11-28 | LYONS GARY A Director | Option exercise · Series B Preferred Stock | +1 | 1 | ||
| 2017-11-28 | LYONS GARY A Director | Option exercise · Warrants (Right to Buy) | +1,800 | 1,800 | ||
| 2017-11-28 | RICKEY DAVID Director | Option exercise · Subscription Rights (Right to Buy) | −6 | 0 | ||
| 2017-11-28 | RICKEY DAVID Director | Option exercise · Series B Preferred Stock | +6 | 6 | ||
| 2017-11-28 | RICKEY DAVID Director | Option exercise · Warrants (Right to Buy) | +10,800 | 10,800 | ||
| 2017-11-28 | Naughton Gail K Director | Option exercise · Subscription Rights (Right to Buy) | −1 | 0 | ||
| 2017-11-28 | Naughton Gail K Director | Option exercise · Series B Preferred Stock | +1 | 1 | ||
| 2017-11-28 | Naughton Gail K Director | Option exercise · Warrants (Right to Buy) | +1,800 | 1,800 | ||
| 2017-11-28 | HEDRICK MARC H President and CEO | Option exercise · Subscription Rights (Right to Buy) | −9 | 0 | ||
| 2017-11-28 | HEDRICK MARC H President and CEO | Option exercise · Series B Preferred Stock | +9 | 9 | ||
| 2017-11-28 | HEDRICK MARC H President and CEO | Option exercise · Warrants (Right to Buy) | +16,200 | 16,200 |
Page 12 of 53 · 1,048 trades